BioCatalyst

DISC-1459 — catalyst calendar

1 verified catalyst event(s) referencing DISC-1459, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
Phase 3 · Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP)
 IRON Disc Medicine, Inc. DISC-1459 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.